Long COVID: learning from patients + looking at what's next

Description:

We will explore the state of Long COVID today—addressing the growing market developing therapeutics and tools, the status of the Long COVID advocacy movement, and what we can learn from HIV/AIDS. We will consider the accommodations and benefits the ~65M people living with Long COVID need to survive and thrive, and the importance of deferring to “long-haulers” when designing policies and support. We will also touch on barriers to accessing care, with a focus on marginalized populations, including low-income people, BIPOC, and LGBTQ+ folks, and the debated appropriateness of the term “patient.”